HopeStage
Back to all studies
Not recruitingISRCTN10761003

Cognitive therapy for depression in tuberculosis treatment

This study has public registry information. It focuses on depression and currently lists study information in Pakistan.

Depression, Mental healthOtherFrom 18 Years to 70 Years
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 70 years.

Compensation and expense reimbursement have not been verified for this summary.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Not recruiting
Enrollment listed in the registry
Not clearly listed
Sponsor
National Institute for Health and Care Research
Sponsor type
Research institute
Study type
Other
Intervention type
Other / unclear
Study phase
Not clearly listed
Locations
Pakistan
Age range
From 18 Years to 70 Years
Official registry ID
ISRCTN10761003
Official title
Cognitive therapy for depression in tuberculosis treatment

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: ISRCTN10761003. We help you review the study, but cannot decide medical eligibility.

Recruitment & locations

Not recruiting

Pakistan

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute for Health and Care Research, a research institute.

Who can participate?

Listed age limits: 18 years to 70 years.

Is this study still recruiting?

The registry lists this study as not recruiting.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me